prolinedithiocarbamate has been researched along with T-Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Alessandro, N; Dusonchet, L; Meli, M; Notarbartolo, M; Rausa, L; Tolomeo, M | 1 |
1 other study(ies) available for prolinedithiocarbamate and T-Cell Lymphoma
| Article | Year |
|---|---|
NF-kappaB inhibition restores sensitivity to Fas-mediated apoptosis in lymphoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; fas Receptor; Humans; Leupeptins; Lymphoma, T-Cell; NF-kappa B; Peptides; Proline; Thiocarbamates | 2003 |